KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to -$1.2 billion.

  • Amgen's Cash from Financing Activities rose 1286.43% to -$1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$10.9 billion, marking a year-over-year decrease of 1533.72%. This contributed to the annual value of -$10.9 billion for FY2025, which is 1533.72% down from last year.
  • Amgen's Cash from Financing Activities amounted to -$1.2 billion in Q4 2025, which was up 1286.43% from -$2.9 billion recorded in Q3 2025.
  • In the past 5 years, Amgen's Cash from Financing Activities ranged from a high of $21.5 billion in Q1 2023 and a low of -$6.6 billion during Q4 2021
  • In the last 5 years, Amgen's Cash from Financing Activities had a median value of -$1.8 billion in 2021 and averaged -$576.7 million.
  • In the last 5 years, Amgen's Cash from Financing Activities tumbled by 66338.58% in 2021 and then soared by 71209.45% in 2023.
  • Quarter analysis of 5 years shows Amgen's Cash from Financing Activities stood at -$6.6 billion in 2021, then skyrocketed by 84.0% to -$1.0 billion in 2022, then surged by 362.54% to $2.8 billion in 2023, then tumbled by 151.09% to -$1.4 billion in 2024, then grew by 12.86% to -$1.2 billion in 2025.
  • Its Cash from Financing Activities was -$1.2 billion in Q4 2025, compared to -$2.9 billion in Q3 2025 and -$2.7 billion in Q2 2025.